Nuloc-D Capsule SR is a combination pharmaceutical formulation containing Domperidone 30 mg and Rabeprazole 20 mg, designed for the management of gastrointestinal disorders characterized by acid-related symptoms and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, and bloating. Rabeprazole, a proton pump inhibitor (PPI), suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, providing effective relief from acid-related conditions including gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease. The sustained-release formulation of Nuloc-D ensures a prolonged therapeutic effect, enhancing patient compliance by reducing dosing frequency. This combination is particularly beneficial in patients with concomitant motility disorders and acid hypersecretion, offering symptomatic relief and promoting mucosal healing. Nuloc-D Capsule SR should be administered as prescribed by a healthcare professional, with caution in patients with known hypersensitivity to its components, hepatic or renal impairment, or underlying cardiac conditions. Regular monitoring and adherence to recommended dosage are essential to minimize potential adverse effects and optimize therapeutic outcomes.

Dosage & How to Use